These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3441405)

  • 21. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early recurrence in oestrogen receptor negative breast carcinomas. A preliminary report.
    Hartveit F; Maartmann-Moe H; Støa KF; Tangen M; Thorsen T
    Acta Chir Scand; 1980; 146(2):93-5. PubMed ID: 7415751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of cytoplasmic estrogen and progesterone receptors in breast carcinoma: comparison of a histochemical and a radiometric method].
    Wolf D; Forti E; Gion M; Melia M; Dittadi R; Mione R
    Pathologica; 1985; 77(1049):305-9. PubMed ID: 3831881
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cell picture and hormone receptor status--visual and image analytical studies of breast cancers].
    Schenck U; Burger G; Jütting U; Eiermann W
    Verh Dtsch Ges Pathol; 1985; 69():529-31. PubMed ID: 4096123
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prognostic value of hormonal receptors determined by a histochemical method in operable carcinoma of the breast. Multicenter study].
    Baiocchi C; De Crescenzo S; Ferrari M
    Pathologica; 1987; 79(1059-1060):149-57. PubMed ID: 3327040
    [No Abstract]   [Full Text] [Related]  

  • 28. [Morphologic and morphometric parameters of infiltrating duct carcinoma of the breast and receptor state in fluorescence: correlations in 104 cases (1983 case survey)].
    Tunesi G; Anselmi L; Bandelloni R; Gambini C; Reale A; Sementa AR; Bronzini E
    Pathologica; 1985; 77(1049):251-8. PubMed ID: 3008066
    [No Abstract]   [Full Text] [Related]  

  • 29. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between histopathological type and biochemical dosage of estradiol and progesterone receptors in women with primary carcinoma of the breast].
    Gebrim LH; de Lima GR; dos Santos HB; Guidugli Neto J; Grabert H
    Rev Paul Med; 1987; 105(4):195-200. PubMed ID: 3454477
    [No Abstract]   [Full Text] [Related]  

  • 31. Carcinoma of the breast: the role of estrogen and other receptor determinations.
    Meyer JS; Stevens SC; White WL
    Mo Med; 1979 Feb; 76(2):89-92. PubMed ID: 423875
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relation between estrogen receptors and the clinical morphological characteristics of primary breast cancer].
    Vishniakova VV; Ermilova VD; Murav'eva NI; Bassalyk LS
    Arkh Patol; 1981; 43(7):20-3. PubMed ID: 7271502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone receptors and precancerous lesions of the breast].
    Mignot L; Espie M; de Roquancourt A; Gorins A
    Pathol Biol (Paris); 1983 Nov; 31(9):761-4. PubMed ID: 6318180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptors in early breast cancer.
    Cooke T; George D; Schields R; Maynard PV; Griffiths K
    Eur J Cancer (1965); 1980; Suppl 1():53-7. PubMed ID: 7318869
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation between estrogen and progesterone receptors and certain pathologic features with prognostic significance in primary invasive breast carcinomas.
    Santini D; Ricci M; Di Palma S; Taffurelli M; Grassigli A; Marrano D
    Arch Anat Cytol Pathol; 1986; 34(2):85-8. PubMed ID: 3777995
    [No Abstract]   [Full Text] [Related]  

  • 36. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
    Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
    J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen and progesterone receptors in human breast cancer.
    Seckinger D
    J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
    [No Abstract]   [Full Text] [Related]  

  • 38. Variation of estrogen and progesterone receptor status in breast cancer.
    Alanko A
    Ann Clin Res; 1985; 17(1):10-4. PubMed ID: 4015025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology.
    Thorpe SM; Rose C
    Cancer Surv; 1986; 5(3):505-25. PubMed ID: 3555780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.